These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11092672)

  • 21. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of patients with hypertension and angina pectoris.
    Bush DE; Bulkley BH
    Am J Med; 1984 Aug; 77(2B):28-34. PubMed ID: 6148886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of calcium antagonists in treatment of cardiovascular disorders.
    Krikler DM; Rowland E
    J Am Coll Cardiol; 1983 Jan; 1(1):355-64. PubMed ID: 6131086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.
    Krikler DM; Harris L; Rowland E
    Am Heart J; 1982 Sep; 104(3):702-8. PubMed ID: 6126115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of angina pectoris with calcium antagonists: long-term follow-up.
    Behar S
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():119-24. PubMed ID: 9642485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.
    Strauss WE; Parisi AF
    Ann Intern Med; 1988 Oct; 109(7):570-81. PubMed ID: 2901816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of triple therapy in patients with chronic stable angina pectoris.
    Crawford MH
    Circulation; 1987 Jun; 75(6 Pt 2):V122-7. PubMed ID: 2882871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
    Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
    J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive drug management of angina pectoris.
    Pepine CJ; Feldman RL; Conti CR
    Cardiovasc Clin; 1984; 14(3):139-51. PubMed ID: 6144388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical therapy of stable angina pectoris.
    Thadani U
    Cardiol Clin; 1991 Feb; 9(1):73-87. PubMed ID: 1674227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium antagonists.
    Conti CR; Pepine CJ; Feldman RL; Hill JA
    Cardiology; 1985; 72(5-6):297-321. PubMed ID: 2866840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of angina pectoris--state of the art].
    Nager F
    Schweiz Rundsch Med Prax; 1990 Mar; 79(10):267-76. PubMed ID: 1969177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-blockaders in first-intention treatment of exercise angina pectoris].
    Witchitz S
    Presse Med; 1987 Sep; 16(30):1473-7. PubMed ID: 2888106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary management of angina: part II. Medical management of chronic stable angina.
    Zanger DR; Solomon AJ; Gersh BJ
    Am Fam Physician; 2000 Jan; 61(1):129-38. PubMed ID: 10643954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of isradipine, alone and in combination, in the treatment of angina pectoris.
    Rüegg PC; Nelson DJ
    Am J Med; 1989 Apr; 86(4A):70-4. PubMed ID: 2565689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.